Tobacco gets new, healthy image

Tobacco use triggers a number of common diseases in humans including heart disease and lung cancer. However, a group of scientists from Europe may be tobacco's saving grace. They successfully used genetically modified tobacco plants to generate medicines for a number of autoimmune and inflammatory diseases. The study was part of the Pharma-Planta project, which was funded under the EU's Sixth Framework Programme (FP6) to the tune of EUR 12 million. The study's results were recently published in the open access journal BMC Biotechnology.

The scientists targeted the creation of transgenic tobacco plants with the capacity to generate biologically-active interleukin-10 (IL-10), a small protein known as a cytokine that regulates the immune system.

Led by Professor Mario Pezzotti from the University of Verona in Italy, the team tested two different versions of IL-10 (viral and murine) and produced plants in which this protein was targeted to three different compartments within the cell in order to assess the most effective one.

The researchers noted that oral administration of this cytokine alone, or in combination with disease-associated autoantigens, could offer protection from the onset of a specific autoimmune disease through the 'induction of oral tolerance'.

Furthermore, the team found that the tobacco plants successfully processed both forms of IL-10. Active cytokine was produced at high enough levels making it possible to use tobacco leaves without wasting a lot of time for extraction or purification. Transgenic plants are able to increase proportionally at low cost and with low maintenance.

"The fact that they can be eaten, which delivers the drug where it is needed, thus avoiding lengthy purification procedures, is another plus compared with traditional drug synthesis," explained Professor Pezzotti. "These results clearly demonstrate that tobacco plants can express the viral and murine IL-10 genes, process and assemble the corresponding proteins into functional, biologically-active dimers," he added.

The scientists are eager to use the plants to determine whether repeated small doses could help prevent type 1 diabetes mellitus (T1DM), in combination with other auto-antigens associated with the disease. They have set their sights on the 65-kDa isoform of the enzyme glutamic acid decarboxylase (GAD65) for the testing.

"The accumulation levels of both viral and murine IL-10 in tobacco leaves are high enough to provide sufficient material for oral administration in oral tolerance studies using the available mouse models," Professor Pezzotti said.

"This study paves the way to performing feeding studies in mouse models of autoimmune diseases, which will allow the evaluation of the immunomodulatory properties and effectiveness of the viral IL-10 in inducing oral tolerance compared to the murine protein."

Collaborating with the University of Verona were the Institute for Molecular Biotechnology (Germany), Fraunhofer Institute for Molecular Biology and Applied Ecology (Germany), Max-Planck-Institute of Molecular Plant Physiology (Germany), the University of Natural Resources and Applied Life Sciences (Austria) and the University of Perugia (Italy).

For further information, please visit:

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AstraZeneca enters license agreement with KYM Bios…

AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targetin...

Pfizer's elranatamab receives FDA and EMA filing a…

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the company's Biologics License Application (BLA) ...

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Nanosatellite shows the way to RNA medicine of the…

The RNA molecule is commonly recognized as messenger between DNA and protein, but it can also be folded into intricate molecular machines. An example of a naturally occur...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...

AI conjures proteins that speed up chemical reacti…

For the first time, scientists have used machine learning to create brand-new enzymes, which are proteins that accelerate chemical reactions. This is an important step in...